Superdrug Owner AS Watson Targets $30bn Dual Listing in London and Hong Kong

Key Facts

Following years of speculation regarding the future of the world's largest health and beauty retailer, AS Watson is moving forward with ambitious dual-listing plans. The company, owned by conglomerate CK Hutchison Holdings Limited, plans to publicly trade shares in both Hong Kong and London before the end of 2026. According to reports, the firm is targeting a valuation of approximately $30 billion, aiming to shrug off recent market volatility to secure a structure that broadens its global investor base.

This move comes at a pivotal time for the global retail sector as investors monitor the performance of peers like Boots, owned by Walgreens Boots Alliance. Per market data, a successful listing would provide a significant boost to the London Stock Exchange, which has struggled to attract major IPOs recently. It also reinforces Hong Kong's status as an Asian financial hub despite slowing retail sales in China, which grew by only 0.2% in May according to official data (Source: China National Bureau of Statistics).

Traders should watch CK Hutchison (0001.HK), which closed at HKD 47.50 on May 22, 2026, as its valuation is directly tied to the IPO's progress. Looking ahead at the economic calendar, upcoming inflation and retail sales data from both the UK and China will be critical catalysts for investor appetite, especially as global consumer spending remains under pressure.